These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1844694)

  • 1. Comparison of treatments in a combination therapy trial.
    Patel HI
    J Biopharm Stat; 1991; 1(2):171-83. PubMed ID: 1844694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The analysis of a multiple-dose, combination-drug clinical trial using response surface methodology.
    Phillips JA; Cairns V; Koch GG
    J Biopharm Stat; 1992; 2(1):49-67. PubMed ID: 1300205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to deal with multiple treatment or dose groups in randomized clinical trials?
    Hothorn LA
    Fundam Clin Pharmacol; 2007 Apr; 21(2):137-54. PubMed ID: 17391286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninferiority testing beyond simple two-sample comparison.
    Tsong Y; Chen WJ
    J Biopharm Stat; 2007; 17(2):289-308. PubMed ID: 17365225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptotic simultaneous confidence intervals for many-to-one comparisons of binary proportions in randomized clinical trials.
    Schaarschmidt F; Biesheuvel E; Hothorn LA
    J Biopharm Stat; 2009; 19(2):292-310. PubMed ID: 19212881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal number of repeated measures and group sizes in clinical trials with linearly divergent treatment effects.
    Winkens B; Schouten HJ; van Breukelen GJ; Berger MP
    Contemp Clin Trials; 2006 Feb; 27(1):57-69. PubMed ID: 16260188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple comparisons and multiple contrasts in randomized dose-response trials--confidence interval oriented approaches.
    Hothorn LA
    J Biopharm Stat; 2006; 16(5):711-31. PubMed ID: 17037267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the interaction between the therapy and the treatment in clinical trials by the propensity score weighting method.
    Fujii Y; Henmi M; Fujita T
    Stat Med; 2012 Feb; 31(3):235-52. PubMed ID: 22253134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical efficiency in multiple-to-one comparison trials with optimal allocation ratio.
    Zhang J; Zhang JJ
    J Biopharm Stat; 2011 Jan; 21(1):125-35. PubMed ID: 21191859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
    Tsong Y; Zhang J
    J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confidence intervals and p-values for Williams' and other step-down multiple comparison tests against control.
    Channon EJ; McEntegart DJ
    J Biopharm Stat; 2001; 11(1-2):45-63. PubMed ID: 11459442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New tests for null hypothesis of non unity ratio of proportions.
    Koti KM
    J Biopharm Stat; 2007; 17(2):229-45. PubMed ID: 17365220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodology of superiority vs. equivalence trials and non-inferiority trials.
    Christensen E
    J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y; Zhang J; Levenson M
    J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline correction in a two-way randomized blocks design.
    Overall JE; Magee KN
    J Biopharm Stat; 1992; 2(2):205-17. PubMed ID: 1300214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global tests for combination drug studies in factorial trials.
    Hung HM
    Stat Med; 1996 Feb; 15(3):233-47. PubMed ID: 8643882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An asymptomatic confidence interval for the response at the stationary point of a quadratic response surface.
    Chinchilli VM; Carter WH; Breen TJ; Campbell ED
    J Biopharm Stat; 1991; 1(2):287-301. PubMed ID: 1844701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive design and estimation in randomized clinical trials with correlated observations.
    Yin G; Shen Y
    Biometrics; 2005 Jun; 61(2):362-9. PubMed ID: 16011682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-inferiority trials: the 'at least as good as' criterion.
    Laster LL; Johnson MF
    Stat Med; 2003 Jan; 22(2):187-200. PubMed ID: 12520556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.